Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers

Clinical trial NCT04082572 · COMPLETED

Trial details

NCT number: NCT04082572
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Malignant Solid Neoplasm

Start date: 2019-10-31
Primary completion: 2024-11-08
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.